Nima Schei

Nima Schei is the CEO of Hummingbirds, a BEL Research Board Member, and a Venture Partner at OneLove Investments. Nima has also been the Co-founder and CEO of PositiveMed and a Graduate Teaching Assistant at Rutgers University - Newark. In addition to their work in the business world, they also serve on the Advisory Board for For The Love of Animals.

Nima Schei has dedicated their career to helping others. As a BEL Research Board Member, they create and promotes the next generations of emotion-based decision markers in the industry. At OneLove Investments, they advise startups in healthcare, digital media and technology. And as the Co-founder and CEO of PositiveMed, they help those in need access quality medical care.

A compassionate leader with a passion for making a difference, Nima Schei is making the world a better place one step at a time.

Nima Schei attended Tehran University of Medical Sciences, where they earned their Doctor of Medicine (MD) degree. Nima then took a leave of absence from Rutgers University, where they were pursuing a Doctor of Philosophy (PhD) in Computational Neuroscience, to attend New York University and study business administration, management and operations.

Hamed Tabkhi - CTO, Sara Zargaran - CMO, and Gregg Stein - CSO report to Nima Schei.